{
    "title": "AstraZeneca warns Covid sales will tumble in 2022 after \u00a33bn jab boost in 2021",
    "url": "https://www.dailymail.co.uk/wires/pa/article-10497449/AstraZeneca-notches-3bn-Covid-jab-sales-2021.html",
    "date": "2022-02-10",
    "keywords": [
        "vaccine",
        "group",
        "jab",
        "year",
        "astrazeneca",
        "covid",
        "world",
        "drug",
        "quarter",
        "profit",
        "percentage",
        "publicity",
        "soriot",
        "research",
        "covid19",
        "supply",
        "takeup",
        "growth",
        "evusheld",
        "antibody",
        "decline",
        "surge",
        "november",
        "cost",
        "hospital",
        "version",
        "uk",
        "booster",
        "blood",
        "clot",
        "john",
        "oxford",
        "university",
        "week",
        "reputation",
        "reception",
        "boosting",
        "anything",
        "youve",
        "astrazenecas",
        "line",
        "loss",
        "spite",
        "exchange",
        "dollar",
        "deal",
        "company",
        "alexion",
        "investment",
        "jump",
        "shareholder",
        "dividend",
        "payout",
        "share",
        "rise",
        "decade"
    ],
    "category": [
        "wires",
        "pa"
    ]
}